191 related articles for article (PubMed ID: 34129075)
21. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
22. In vivo effects of 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A) and alpha-difluoromethylornithine (DFMO) on L1210 growth, cell-cycle phase distribution and polyamine contents.
Dorhout B; te Velde RJ; Ferwerda H; Kingma AW; de Hoog E; Muskiet FA
Int J Cancer; 1995 Sep; 62(6):738-42. PubMed ID: 7558423
[TBL] [Abstract][Full Text] [Related]
23. Characterising the Response of Human Breast Cancer Cells to Polyamine Modulation.
Akinyele O; Wallace HM
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067619
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines.
Makena MR; Cho HE; Nguyen TH; Koneru B; Verlekar DU; Hindle A; Kang MH; Reynolds CP
Pediatr Blood Cancer; 2018 Dec; 65(12):e27447. PubMed ID: 30251395
[TBL] [Abstract][Full Text] [Related]
25. Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
Bassiri H; Benavides A; Haber M; Gilmour SK; Norris MD; Hogarty MD
Transl Pediatr; 2015 Jul; 4(3):226-38. PubMed ID: 26835380
[TBL] [Abstract][Full Text] [Related]
26. Isolation and characterization of human breast adenocarcinoma cells made resistant to alpha-difluoromethylornithine.
Das B; Vig M; Khurana KK; Madhubala R
Cancer Invest; 2000; 18(2):115-22. PubMed ID: 10705873
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
[TBL] [Abstract][Full Text] [Related]
28. [Antitumor effect of alpha-difluoromethylornithine (DFMO) changes in ornithine decarboxylase (ODC) activity and polyamine (PA) levels in human tumor transplanted into nude mice].
Umemoto S
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):650-60. PubMed ID: 2507897
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of increases in ornithine decarboxylase and putrescine has no effect on rat liver regeneration.
Beyer HS; Ellefson M; Stanley M; Zieve L
Am J Physiol; 1992 Apr; 262(4 Pt 1):G677-84. PubMed ID: 1566849
[TBL] [Abstract][Full Text] [Related]
30. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
32. Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma.
Grossie VB; Ota DM; Ajani JA; Nishioka K
Cancer Res; 1987 Apr; 47(7):1836-40. PubMed ID: 3102050
[TBL] [Abstract][Full Text] [Related]
33. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells.
Selamnia M; Mayeur C; Robert V; Blachier F
Biochem Pharmacol; 1998 Apr; 55(8):1241-5. PubMed ID: 9719479
[TBL] [Abstract][Full Text] [Related]
34. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
[TBL] [Abstract][Full Text] [Related]
35. Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells.
Manni A; Washington S; Hu X; Griffith JW; Bruggeman R; Demers LM; Mauger D; Verderame MF
Clin Exp Metastasis; 2005; 22(3):255-63. PubMed ID: 16158253
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of polyamine biosynthesis preserves β cell function in type 1 diabetes.
Sims EK; Kulkarni A; Hull A; Woerner SE; Cabrera S; Mastrandrea LD; Hammoud B; Sarkar S; Nakayasu ES; Mastracci TL; Perkins SM; Ouyang F; Webb-Robertson BJ; Enriquez JR; Tersey SA; Evans-Molina C; Long SA; Blanchfield L; Gerner EW; Mirmira RG; DiMeglio LA
Cell Rep Med; 2023 Nov; 4(11):101261. PubMed ID: 37918404
[TBL] [Abstract][Full Text] [Related]
37. Polyamines as biomarkers of cervical intraepithelial neoplasia.
Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
[TBL] [Abstract][Full Text] [Related]
38. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro.
Takigawa M; Enomoto M; Nishida Y; Pan HO; Kinoshita A; Suzuki F
Cancer Res; 1990 Jul; 50(13):4131-8. PubMed ID: 1693880
[TBL] [Abstract][Full Text] [Related]
39. pH gradient-liquid chromatography tandem mass spectrometric assay for determination of underivatized polyamines in cancer cells.
Cho HE; Kang MH
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1085():21-29. PubMed ID: 29626790
[TBL] [Abstract][Full Text] [Related]
40. In vivo enhancement of herpes simplex virus thymidine kinase/ganciclovir cancer gene therapy with polyamine biosynthesis inhibition.
Wahlfors T; Hakkarainen T; Jänne J; Alhonen L; Wahlfors J
Int J Cancer; 2006 Jun; 118(11):2907-10. PubMed ID: 16385565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]